Centre Eugène Marquis

Recent papers from Centre Eugène Marquis

1. Treatment outcomes of tucatinib in combination with trastuzumab and pertuzumab as a maintenance therapy for people with HER2+ metastatic breast cancer: a plain language summary of findings from HER2CLIMB-05Future Oncology · 2026
2. Descriptive Analysis of Epidemiology, Demographic Characteristics, and Survival of Dedifferentiated Liposarcoma in FranceInternational Journal of Cancer · 2026
3. Radiopharmaceutical Therapy with [ 177 Lu]Lu-DOTATATE in Refractory Meningiomas: Results from the French Multicenter MELUTE CohortJournal of Nuclear Medicine · 2026
4. ATF4 and ATF6 orchestrate transcriptional responses to glucose deprivation in NSCLCCancer & Metabolism · 2026
5. Reference frame for Adult Brainstem gliomasThe Oncologist · 2026
6. Efficacy and safety of pembrolizumab–lenvatinib in metastatic endometrial cancer: results from the French multicenter early access programESMO Open · 2026
7. Explaining educational differences in return to work after early breast cancer: a mediation analysis.2026
8. Tucatinib, trastuzumab, and capecitabine as second- or third-line therapy after trastuzumab deruxtecan in HER2-positive metastatic breast cancer: A multicenter retrospective study in FranceThe Breast · 2026
9. Evaluation of the nutritional and digestive impact of irradiation in nasopharyngeal cancers: the French multicenter retrospective DRAKAR studyClinical and Translational Radiation Oncology · 2026
10. Prospective circulating tumour DNA surveillance in patients with early high-risk hormone receptor positive, HER2-negative breast cancer in the TRAK-ER studyAnnals of Oncology · 2026
11. Immune checkpoint inhibitors in advanced upper-tract urothelial carcinoma: a multicenter studyScientific Reports · 2026
12. CReP-mediated control of eIF2α phosphorylation is a critical node in MYC-driven medulloblastomaNature Communications · 2026
13. Compartmentalisation of death receptor signalling in cancerOncogenesis · 2026
14. Real-world data from patients treated with chemotherapy for biliary tract cancer: insights from a prognostic model. ☆JHEP Reports · 2026
15. How to improve the implementation of new radiotherapy guidelines? Interests and limits of a national training workshopBritish Journal of Radiology · 2026
16. The (European) protein homeostasis networkFEBS Journal · 2026
17. Variability and Main Determinants of Planning Target Volume During Cardiac Stereotactic Radioablation for Refractory Ventricular Arrhythmias: A Systematic Review and Pooled AnalysisJournal of Cardiovascular Electrophysiology · 2026
18. Rationale and trial design of RIBOLARIS: A phase II trial of neoadjuvant and adjuvant ribociclib plus endocrine therapy for clinically high-risk HR+/HER2-negative breast cancerTherapeutic Advances in Medical Oncology · 2026
19. Phase I safety, efficacy, and biomarker response evaluations of three oral PD-L1 inhibitors: INCB086550, INCB099280, and INCB099318Journal for ImmunoTherapy of Cancer · 2026
20. Deni Study: Real‐World Data on the Use of Nirogacestat in Patients With Desmoid Tumors in the French Sarcoma GroupInternational Journal of Cancer · 2026